Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Steven Lietman, MD

216.444.2606

Steven Lietman, MD

Appointed: 2004

Steven Lietman, MD
Department: Orthopaedic Surgery
Co-Director, Musculoskeletal Tumor Center
Location: Cleveland Clinic Main Campus
Mail Code A41
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2606
DeskDesk:216.445.2742
WorkFax:216.445.6255
Steven Lietman, MD
Department: Taussig Cancer Institute
Location: Cleveland Clinic Main Campus
Mail Code A41
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2606
DeskDesk:216.445.2742
WorkFax:216.445.6255
Steven Lietman, MD
Department: Transplantation Center
Location: Cleveland Clinic Main Campus
Mail Code A41
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2606
DeskDesk:216.445.2742
WorkFax:216.445.6255
Steven Lietman, MD
Department: Biomedical Engineering
Location: Cleveland Clinic Main Campus
Mail Code A41
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2742
DeskDesk:216.445.2742
WorkFax:216.445.6255
Surgeon:
Yes
Treats:
Both Adults and Children & Adolescents

Biographical Sketch

Steven Lietman, MD, was appointed to Cleveland Clinic in 2004. Dr Lietman comes from Johns Hopkins where he had a very busy surgical practice and was the recipient of both the Johns Hopkins University School of Medicine Clinical-Scientist Award and the Orthopaedic Research and Education Foundation Career Development Award.

He is the Principal Investigator on the Orthopaedic Research and Education Foundation Career Development Award and an NIH KO8 grant.

His specialty interests are bone and soft tissue tumors and total joint replacement, and recent research includes studies into molecular mechanisms of ectopic bone formation and bone resorption and sarcomas.

Dr. Lietman is a member of the International Society of Limb Salvage, the American Academy of Orthopaedic Surgeons, American Society of Bone and Mineral Research, the Orthopaedic Research Society, the Musculoskeletal Tumor Society and the American Orthopaedic Association.

Education & Fellowships

Fellowship - Massachusetts General Hospital
Orthopaedic Oncology
Boston, MA USA
1996
Fellowship - Johns Hopkins Hospital
Research
Baltimore, MD USA
1995
Residency - Johns Hopkins Hospital
Orthopaedic Surgery
Baltimore, MD USA
1993
Internship - Johns Hopkins Hospital
Orthopaedic Surgery
Baltimore, MD USA
1989
Medical School - Dartmouth Medical School
Hanover, NH USA
1988
Undergraduate - Dartmouth College
Hanover, NH USA
1984

Certifications

  • Orthopaedic Surgery

Specialty Interests

Orthopedic oncology, adult reconstruction

Awards & Honors

  • American Academy of Orthopaedic Surgeons/Orthopaedic Research and Education Foundation, Clinician Scientist Traveling Fellow (7/05-6/06)
  • Orthopaedic Research and Education Foundation, Career Development Award (4/01/02-3/31/05)
  • Johns Hopkins University School of Medicine, Clinician-Scientist Award (01/01/01-12/31/02)
  • Dartmouth Medical School, Second Prize, Boehringer Ingleheim Essay Contest (1985)
  • Dartmouth College, Hendrick Award (1984)
  • Scholar Athlete (1980) St. Paul's School
  • Charles B. Pforr Memorial Cup (1980) St. Paul's School
  • Co-captain Varsity Lacrosse (1984) Dartmouth College
  • Second Team, All New England (1982-1984) Dartmouth College
  • Honorable Mention, All Ivy (1982, 1984) Dartmouth College

Innovations & Patents

Cleveland Clinic Innovation Award (2007) for Novel Treatment in Bone Resorption

Memberships

  • American Academy of Orthopaedic Surgeons, 1999
  • American Society of Bone and Mineral Research, 2000
  • Orthopaedic Research Society, 2002
  • Musculoskeletal Tumor Society, 2005
  • American Orthopaedic Association, 2007

Treatment & Services

  • Amputation
  • Arthritis Surgery
  • Arthroplasty
  • Complex Primary Hip Arthroplasty
  • Complex Primary Knee Arthroplasty
  • Fracture Non-union
  • Fracture Reconstruction
  • Hip & Knee Surgery
  • Hip Replacement
  • Joint Aspiration
  • Joint Replacement
  • Joint Replacement Of The Knee
  • Knee Arthroscopy
  • Knee Surgery
  • Minimally Invasive Surgery
  • Orthopaedic Surgery
  • Primary And Revision Joint Replacements
  • Primary And Revision Total Hip Arthroplasty
  • Primary And Revision Total Knee Arthroplasty
  • Reconstructive Surgery Of The Hip
  • Reconstructive Surgery Of The Knee
  • Resurfacing Total Hip Arthroplasty
  • Revision Hip Arthroplasty
  • Revision Hip Joint Replacement
  • Revision Joint Replacement
  • Revision Knee Arthroplasty
  • Revision Knee Joint Replacement
  • Revision Total Hip Replacement
  • Revision Total Knee Replacement
  • Surgery
  • Surgical Treatment Of Arthritis Of The Hips And Knees
  • Therapeutic Injections
  • Total Hip And Total Knee Replacement
  • Total Joint Replacement
  • Total Knee Replacement

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 7/30/2014, Dr. Lietman has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English